How the Macular Edema and Macular Degeneration Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Drivers Are Shaping the Growth and Development of theMacular Edema and Macular Degeneration Market?
The upward trend in diabetes sufferers is anticipated to motivate a surge in the rise of the macular edema and macular degeneration market in the future. Diabetes, a chronic health issue defined by elevated blood glucose (sugar) levels, causes harm to the eye’s blood vessels, potentially causing macular edema and macular degeneration. For example, The National Health Service (NHS England), a publicly funded healthcare system based in the UK, stated in June 2024 that the number of people diagnosed with pre-diabetes by the NHS in England increased to 3,615,330 in 2023, up 18% from 3,065,825 in 2022. Moreover, pre-diabetic cases under the age of 40 soared almost 25%, growing from 173,166 in 2022 to 216,440 in 2023. Hence, the escalating diabetes population is fueling the expansion of the macular edema and macular degeneration market.
Macular Edema and Macular Degeneration Market Driver: Surge Of Eye Disorders Catalyses The Expansion of Macular Edema And Macular Degeneration Market
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13479&type=smp
How Has the Macular Edema and Macular Degeneration Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?
The market size for macular edema and macular degeneration has experienced robust growth in the last few years. The market, which is projected at $9.65 billion in 2024, is poised to rise to $10.43 billion in 2025, marking a compound annual growth rate (CAGR) of 8.1%. The notable growth witnessed in the past can be ascribed to factors such as an aging population, an increase in diabetes cases, awareness and early detection, global strides in eye health, pharmaceutical breakthroughs, and sustained efforts towards patient advocacy and support.
The market for macular edema and macular degeneration is projected to experience robust growth in the coming years, reaching a valuation of $13.71 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 7.1%. This anticipated growth during the forecast period is linked to personalized medicine techniques, increasing awareness in burgeoning markets, emphasis on combined therapies, incorporation of teleophthalmology services, and a rise in global aging demographics. Key trends within this forecasted time include progress in sustained-release drug delivery, incorporation of gene therapies, the creation of new imaging technologies, personalized treatment models based on biomarkers, use of teleophthalmology for distant monitoring, and advancements in AI for diagnostics.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13479
Which Cutting-Edge Market Trends Are Expected to Drive theMacular Edema and Macular Degeneration Market’s Growth?
Key players in the machine learning operations sector are introducing innovative tools like GPT Monitoring for MLOps for real-time observation and cost control of GPT models, thereby enhancing the efficiency and performance of the engineering teams. The GPT Monitoring for MLOps technique leverages generative pre-trained transformers to augment the supervision and administration of machine learning operations, thus improving model performance tracking and informed decision-making. For example, New Relic, an American digital intelligence firm, rolled out New Relic Machine Learning Operations (MLOps) in March 2023 for real-time surveillance of applications developed using OpenAI’s GPT series APIs. This advanced feature enables the engineering teams to monitor performance and costs with a simple two-line code, thereby providing immediate observability and deep insights into GPT usage. It supports all current OpenAI GPT versions, giving companies the ability to optimize AI-centered applications and minimize operational costs.
What Are the Leading Market Players Impacting theMacular Edema and Macular Degeneration Market’s Growth Trend?
Major companies operating in the macular edema and macular degeneration market report are F. Hoffmann La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, GlaxoSmithKline PLC, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Bausch Health Companies Inc., Clover Therapeutics Inc., Santen Pharmaceutical Co. Ltd., Samsung Bioepis Inc., PanOptica Inc., Regen X Bio Inc., Aerie Pharmaceutical Inc., Apellis Pharmaceuticals Inc., Kubota Pharmaceutical Holdings Co. Ltd., Alimera Sciences Inc., Kodiak Sciences Inc., Acucela Inc., Editas Medicine Inc., IVERIC bio Inc., Lineage Cell Therapeutics Inc., Allegro Ophthalmic Ltd., Ampio Pharmaceuticals Inc., Neurotech Pharmaceuticals Inc., Graybug Vision Inc., Clearside Biomedical Inc., Ocugen Inc., Opthea Limited
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Macular Edema and Macular Degeneration Market Driving Opportunities and Innovations?
The macular edema and macular degeneration market covered in this report is segmented –
1) By Treatment Type: Drug Therapy, Laser Treatment
2) By Application: Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry age-related macular degeneration, Wet age-related macular degeneration
3) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Drug Therapy: Anti-VEGF (Vascular Endothelial Growth Factor) Injections, Steroid Injections, Oral Medications, Combination Therapy (Anti-VEGF + Steroids)
2) By Laser Treatment: Focal Laser Photocoagulation, Panretinal Photocoagulation (PRP), Subthreshold Laser Therapy, MicroPulse Laser Therapy
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13479&type=smp
What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theMacular Edema and Macular Degeneration Market?# Market Expansion?
North America was the largest region in the macular edema and macular degeneration market in 2024. The regions covered in the macular edema and macular degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Macular Edema and Macular Degeneration Market 2025, By The Business Research Company:
Hyperlipidemia Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hyperlipidemia-global-market-report
Progressive Multifocal Leukoencephalopathy Treatment Global Market Report 2024
Macular Degeneration Treatment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
